MoneyWorks4Me

Shree Ganesh Remed. - Quaterly Results

23 Oct 2022 Evaluate
The sales surged to Rs. 212.60 millions, up 25.29% for the September 2022 quarter as against Rs. 169.69 millions during the corresponding quarter previous year.Net Profit recorded in the quarter ended September 2022 rise to 30.45% to Rs. 39.37  millions  compared to R. 30.18 millions in corresponding previous quarter.Operating profit for the quarter ended September 2022 rose to 60.53 millions as compared to 48.84 millions of corresponding quarter ended September 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 212.60 169.69 25.29 388.99 296.02 31.41 712.88 490.82 45.24
Other Income 7.27 4.40 65.23 13.80 15.48 -10.85 35.68 20.95 70.31
PBIDT 60.53 48.84 23.94 109.54 90.47 21.08 214.88 157.42 36.50
Interest -1.44 0.28 -614.29 0.47 0.98 -52.04 1.46 0.68 114.71
PBDT 61.97 48.56 27.62 109.07 89.49 21.88 213.42 156.74 36.16
Depreciation 9.02 9.54 -5.45 17.22 17.69 -2.66 33.37 27.25 22.46
PBT 52.95 39.02 35.70 91.85 71.80 27.92 180.05 129.49 39.05
TAX 13.58 8.84 53.62 23.82 18.25 30.52 46.07 31.96 44.15
Deferred Tax -0.07 -0.14 -50.00 -0.26 -0.17 52.94 -0.39 -0.36 8.33
PAT 39.37 30.18 30.45 68.03 53.55 27.04 133.98 97.53 37.37
Equity 120.07 100.06 20.00 120.08 100.06 20.01 120.08 100.06 20.01
PBIDTM(%) 28.47 28.78 -1.08 28.16 30.56 -7.86 30.14 32.07 -6.02
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..